Genmab A (GMAB) Property, Plant & Equipment (Net) (2019 - 2026)

Genmab A (GMAB) Property, Plant & Equipment (Net) (2019 - 2026) Analysis & Trends

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Property, Plant & Equipment (Net) (Qtr)
1	Oculis Holding AG	66,621.14 Bn	66,620.85 Bn	-	642,333.36
2	Nanobiotix	1,915.18 Bn	1,915.11 Bn	-	5.32 Mn
3	Akari Therapeutics	1,014.18 Bn	1,014.18 Bn	-	-
4	BeOne Medicines	471.27 Bn	466.48 Bn	1.35 Bn	1.64 Bn
5	Vertex Pharmaceuticals	121.81 Bn	114.57 Bn	2.59 Bn	1.61 Bn
6	Regeneron Pharmaceuticals	69.58 Bn	60.82 Bn	3.31 Bn	5.27 Bn
7	Belite Bio	62.72 Bn	62.72 Bn	-	-
8	Argenx Se	55.51 Bn	50.33 Bn	1.41 Bn	1.96 Bn
9	Revolution Medicines	37.35 Bn	37.35 Bn	-	31.48 Mn
10	Genmab A	1.87 Bn	349.77 Mn	831.00 Mn	143.00 Mn

Download Data